Certified by Founder
Lodge
Xenocor
start up
United States
- Salt Lake City, Utah
- 19/04/2023
- Series A
- $10,000,000
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources
- Industry Medical Equipment Manufacturing
- Website https://xenocor.com/
- LinkedIn https://www.linkedin.com/company/xenocor/
Related People
Charles DeCoster IVFounder
United States -
Washington, Utah
Life Sciences senior leader specializing in Investor Relations, Strategy, Business Development/M&A, Upstream Marketing and Portfolio Management
Project Eleven | $20,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
GovDash | $30,000,000 | (Jan 16, 2026)
RouteSense | $2,000,000 | (Jan 16, 2026)
Vista AI | $29,500,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Slips | $3,500,000 | (Jan 16, 2026)
FOVC | $2,000,000 | (Jan 16, 2026)
VoiceRun | $5,500,000 | (Jan 16, 2026)
Emversity | $30,000,000 | (Jan 16, 2026)
Ammobia | $7,500,000 | (Jan 16, 2026)
Pinch AI | $5,000,000 | (Jan 16, 2026)